Home > Products > CD64 & HER2
> Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Minibody)
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Minibody) (CAT#: MiniB-128)
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Minibody) is designed to be expressed as the anti-CD64 scFv fused to N-terminus of Knob-CH3 domain and the anti-HER2 scFv to the Hole-CH3 domain, or vice versa. The CH3 domains are further stabilized by C-terminal disulfide bonds. This BsAb can retarget neutrophils cells to tumor cells. It is designed for the research of Breast cancer; Gastric cancer; Prostate cacncer; Ovarian cancer; Solid tumors therapy.
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
There are currently no customer reviews or questions for Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Minibody) (MiniB-128). Click the button below to contact us or submit your feedback about this product.